Sanofi will build a $431.5 million vaccine manufacturing plant in Toronto in an effort to double the company's vaccine output by 2023. Construction of the 150,000-square-foot facility at its Canadian headquarters is expected to be completed by 2021.
Sanofi plans vaccine manufacturing plant in Toronto, aims to double output
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.